All IndicationsImmunology & InflammationPhase 3Phase 3Phase 3Phase 2
🛡️
Lupus Nephritis
3
Companies
5
Drug Programs
3
Phase 3
0
Upcoming PDUFAs
Competitors
AUPH
Aurinia Pharmaceuticals Inc.
Placebo Oral Capsule
AUPH
Aurinia Pharmaceuticals Inc.
Voclosporin
ALPN
Alpine Immune Sciences, Inc.
Povetacicept
AUPH
Aurinia Pharmaceuticals Inc.
Voclosporin High Dose
FATE
Fate Therapeutics
FT819
| Company | Drug | Phase | Designations | Timeline | Trial ID |
|---|---|---|---|---|---|
| AUPH Aurinia Pharmaceuticals Inc. | Placebo Oral Capsule | Phase 3 | — | — | — |
| AUPH Aurinia Pharmaceuticals Inc. | Voclosporin | Phase 3 | — | — | — |
| ALPN Alpine Immune Sciences, Inc. | Povetacicept | Phase 3 | — | — | — |
| AUPH Aurinia Pharmaceuticals Inc. | Voclosporin High Dose | Phase 2 | — | — | — |
| FATE Fate Therapeutics | FT819 | — | — | — | — |
Development Stage Distribution
Unknown
1
Phase 3
3
Phase 2
1
PDUFA Timeline
No upcoming PDUFA dates for this indication.
Not financial advice
Signals are probabilistic and based on historical data — past performance doesn't guarantee future results. Do your own research.